Discovery of bioactive molecules from CuAAC click-chemistry-based combinatorial libraries

Drug Discovery Today

Volumn 21, Issue 1, 2016, Pages 118-132

  Wang, Xueshun ^a   Huang, Boshi ^a   Liu, Xinyong ^a   Zhan, Peng ^a  

^a SHANDONG UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CUPROUS ION; DRUG;

CATALYST; CLICK CHEMISTRY; COMBINATORIAL LIBRARY; CYCLOADDITION; DRUG DESIGN; DRUG DEVELOPMENT; IN SITU SCREENING; PHARMACOPHORE; REVIEW; SCREENING; COMBINATORIAL CHEMISTRY; PROCEDURES;

CLICK CHEMISTRY; COMBINATORIAL CHEMISTRY TECHNIQUES; DRUG DISCOVERY;

EID: 84960203206     PISSN: 13596446     EISSN: 18785832     Source Type: Journal    
DOI: 10.1016/j.drudis.2015.08.004     Document Type: Review

References (91)

1. W.L. Jorgensen Efficient drug lead discovery and optimization Acc. Chem. Res. 42 2009 724 733
2. L.M. Mayr, and D. Bojanic Novel trends in high-throughput screening Curr. Opin. Pharmacol. 9 2009 580 588
3. S.L. Schreiber Target-oriented and diversity-oriented organic synthesis in drug discovery Science 287 2000 1964 1969
4. D.E. Scott, and et al. Fragment-based approaches in drug discovery and chemical biology Biochemistry 51 2012 4990 5003
5. J. Kim, and et al. Privileged structures: efficient chemical "navigators" toward unexplored biologically relevant chemical spaces J. Am. Chem. Soc. 136 2014 14629 14638
6. C.A. Olsen, and M.R. Ghadiri Discovery of potent and selective histone deacetylase inhibitors via focused combinatorial libraries of cyclic alpha3beta-tetrapeptides J. Med. Chem. 52 2009 7836 7846
7. M.G. Baud, and et al. Defining the mechanism of action and enzymatic selectivity of psammaplin A against its epigenetic targets J. Med. Chem. 55 2012 1731 1750
8. P. Thirumurugan, and et al. Click chemistry for drug development and diverse chemical-biology applications Chem. Rev. 113 2013 4905 4979
9. H.C. Kolb, and et al. Click chemistry: diverse chemical function from a few good reactions Angew. Chem. Int. Ed. Engl. 40 2001 2004 2021
10. C.W. Tornøe, and et al. Peptidotriazoles on solid phase: [1,2,3]-triazoles by regiospecific copper(i)-catalyzed 1,3-dipolar cycloadditions of terminal alkynes to azides J. Org. Chem. 67 2002 3057 3064
11. J.M. Holub, and K. Kirshenbaum Tricks with clicks: modification of peptidomimetic oligomers via copper-catalyzed azide-alkyne [3 + 2] cycloaddition Chem. Soc. Rev. 39 2010 1325 1337
12. H.C. Kolb, and K.B. Sharpless The growing impact of click chemistry on drug discovery Drug Discov. Today 8 2003 1128 1137
13. K.A. Kalesh, and et al. The use of click chemistry in the emerging field of catalomics Org. Biomol. Chem. 8 2010 1749 1762
14. G.C. Tron, and et al. Click chemistry reactions in medicinal chemistry: applications of the 1,3-dipolar cycloaddition between azides and alkynes Med. Res. Rev. 28 2008 278 308
15. B.T. Worrell, and et al. Direct evidence of a dinuclear copper intermediate in Cu(I)-catalyzed azide-alkyne cycloadditions Science 340 2013 457 460
16. M. Meldal, and C.W. Tornøe Cu-catalyzed azide-alkyne cycloaddition Chem. Rev. 108 2008 2952 3015
17. X.P. He, and et al. CuAAC click chemistry accelerates the discovery of novel chemical scaffolds as promising protein tyrosine phosphatases inhibitors Curr. Med. Chem. 19 2012 2399 2405
18. X.L. Hu, and et al. Triazole-linked glycolipids enhance the susceptibility of MRSA to β-lactam antibiotics ACS Med. Chem. Lett. 6 2015 793 797
19. R. Srinivasan, and et al. Methods of using click chemistry in the discovery of enzyme inhibitors Nat. Protoc. 2 2007 2655 2664
20. R. Berg, and B.F. Straub Advancements in the mechanistic understanding of the copper-catalyzed azide-alkyne cycloaddition Beilstein J. Org. Chem. 9 2013 2715 2750
21. H.C. Liang, and et al. A bis-acetonitrile two-coordinate copper(I) complex: synthesis and characterization of highly soluble B(C(6)F(5))(4)(-) salts of [Cu(MeCN)(2)](+) and [Cu(MeCN)(4)](+) Inorg. Chem. 41 2002 2209 2212
22. R.M. Moorman, and et al. Halide inhibition of the copper-catalysed azide-alkyne cycloaddition Org. Biomol. Chem. 13 2015 1974 1978
23. S.G. Agalave, and et al. Click chemistry: 1,2,3-triazoles as pharmacophores Chem. Asian J. 6 2011 2696 2718
24. A. Massarotti, and et al. Are 1,4- and 1,5-disubstituted 1,2,3-triazoles good pharmacophoric groups? ChemMedChem 9 2014 2497 2508
25. A. Brik, and et al. 1,2,3-triazole as a peptide surrogate in the rapid synthesis of HIV-1 protease inhibitors ChemBioChem 6 2005 1167 1169
26. N. Ma, and et al. The application of click chemistry in the synthesis of agents with anticancer activity Drug Des. Dev. Ther. 9 2015 1585 1599
27. Y.L. Angell, and K. Burgess Peptidomimetics via copper-catalyzed azide-alkyne cycloadditions Chem. Soc. Rev. 36 2007 1674 1689
28. L.V. Lee, and et al. A potent and highly selective inhibitor of human alpha-1,3-fucosyltransferase via click chemistry J. Am. Chem. Soc. 125 2003 9588 9589
29. J. Wang, and et al. Rapid assembly of matrix metalloprotease inhibitors using click chemistry Org. Lett. 8 2006 3821 3824
30. M. Hu, and et al. In situ "click" assembly of small molecule matrix metalloprotease inhibitors containing zinc-chelating groups Org. Lett. 10 2008 5529 5531
31. R. Srinivasan, and et al. Rapid assembly and in situ screening of bidentate inhibitors of protein tyrosine phosphatases Org. Lett. 8 2006 713 716
32. R. Srinivasan, and et al. High-throughput synthesis of azide libraries suitable for direct "click" chemistry and in situ screening Org. Biomol. Chem. 7 2009 1821 1828
33. L.P. Tan, and et al. High-throughput discovery of Mycobacterium tuberculosis protein tyrosine phosphatase B (MptpB) inhibitors using click chemistry Org. Lett. 11 2009 5102 5105
34. X. Zhang, and et al. Salicylic acid based small molecule inhibitor for the oncogenic Src homology-2 domain containing protein tyrosine phosphatase-2 (SHP2) J. Med. Chem. 53 2010 2482 2493
35. S.L. Ng, and et al. "Click" synthesis of small-molecule inhibitors targeting caspases Org. Biomol. Chem. 6 2008 844 847
36. K.A. Kalesh, and et al. Rapid synthesis of Abelson tyrosine kinase inhibitors using click chemistry Org. Biomol. Chem. 7 2009 5129 5136
37. R. Duval, and et al. Rapid discovery of triazolobenzylidene-thiazolopyrimidines (TBTP) as CDC25 phosphatase inhibitors by parallel click chemistry and in situ screening J. Comb. Chem. 11 2009 947 950
38. G. Colombano, and et al. A novel potent nicotinamide phosphoribosyltransferase inhibitor synthesized via click chemistry J. Med. Chem. 53 2010 616 623
39. L. Díaz, and et al. New glucocerebrosidase inhibitors by exploration of chemical diversity of N-substituted aminocyclitols using click chemistry and in situ screening J. Med. Chem. 54 2011 2069 2079
40. C.D. Rillahan, and et al. On-chip synthesis and screening of a sialoside library yields a high affinity ligand for Siglec-7 ACS Chem. Biol. 8 2013 1417 1422
41. P. Elías-Rodríguez, and et al. Rapid discovery of potent α-fucosidase inhibitors by in situ screening of a library of (pyrrolidin-2-yl)triazoles Org. Biomol. Chem. 12 2014 5898 5904
42. J. Yoon, and J.S. Ryu A rapid synthesis of lavendustin-mimetic small molecules by click fragment assembly Bioorg. Med. Chem. Lett. 20 2010 3930 3935
43. D. Song, and et al. Click approach to the discovery of 1,2,3-triazolylsalicylamides as potent aurora kinase inhibitors Bioorg. Med. Chem. 22 2014 4855 4866
44. A. Brik, and et al. Rapid diversity-oriented synthesis in microtiter plates for in situ screening of HIV protease inhibitors ChemBioChem 4 2003 1246 1248
45. M. Whiting, and et al. Rapid discovery and structure-activity profiling of novel inhibitors of human immunodeficiency virus type 1 protease enabled by the copper(I)-catalyzed synthesis of 1,2,3-triazoles and their further functionalization J. Med. Chem. 49 2006 7697 7710
46. T. Suzuki, and et al. Rapid discovery of highly potent and selective inhibitors of histone deacetylase 8 using click chemistry to generate candidate libraries J. Med. Chem. 55 2012 9562 9575
47. T. Suzuki, and et al. Identification of highly selective and potent histone deacetylase 3 inhibitors using click chemistry-based combinatorial fragment assembly PLOS ONE 8 2013 e68669
48. T. Suzuki, and et al. Design, synthesis, and biological activity of NCC149 derivatives as histone deacetylase 8-selective inhibitors ChemMedChem 9 2014 657 664
49. P.R. Tatum, and et al. Identification of novel SIRT2-selective inhibitors using a click chemistry approach Bioorg. Med. Chem. Lett. 24 2014 1871 1874
50. T. Irie, and et al. Design and combinatorial synthesis of a novel kinase-focused library using click chemistry-based fragment assembly Bioorg. Med. Chem. Lett. 22 2012 591 596
51. M. Gehringer, and et al. Solution-phase parallel synthesis of ruxolitinib-derived Janus kinase inhibitors via copper catalyzed azide-alkyne cycloaddition ACS Comb. Sci. 17 2015 5 10
52. P. Zhan, and et al. Design strategies of novel NNRTIs to overcome drug resistance Curr. Med. Chem. 16 2009 3903 3917
53. D. Kang, and et al. "Old dogs with new tricks": exploiting alternative mechanisms of action and new drug design strategies for clinically validated HIV targets Mol. Biosyst. 10 2014 1998 2022
54. P. Bose, and et al. Histone deacetylase inhibitor (HDACI) mechanisms of action: emerging insights Pharmacol. Ther. 143 2014 323 336
55. K. Helin, and D. Dhanak Chromatin proteins and modifications as drug targets Nature 502 2013 480 488
56. P. Mellini, and et al. Sirtuin modulators: an updated patent review (2012-2014) Expert Opin. Ther. Pat. 25 2015 5 15
57. M. Rask-Andersen, and et al. Advances in kinase targeting: current clinical use and clinical trials Trends Pharmacol. Sci. 35 2014 604 620
58. G. Thoma, and et al. Selective inhibitors of the Janus kinase Jak3 - are they effective? Bioorg. Med. Chem. Lett. 24 2014 4617 4621
59. Y. Song, and et al. Multivalent agents: A novel concept and preliminary practice in Anti-HIV drug discovery Curr. Med. Chem. 20 2013 815 832
60. Y. Song, and et al. 8-Hydroxyquinoline: A privileged structure with broad-ranging pharmacological potentials Med. Chem. Commun. 6 2015 61 74
61. Y. Song, and et al. Heterocycle-thioacetic acid motif: A privileged molecular scaffold with potent, broad-ranging pharmacological activities Curr. Pharm. Des. 19 2013 7141 7154
62. Y. Song, and et al. Privileged scaffolds or promiscuous binders: A glance of pyrrolo[2,1-f][1,2,4]triazines and related bridgehead nitrogen heterocycles in medicinal chemistry Curr. Pharm. Des. 19 2013 1528 1548
63. Y. Song, and et al. "Old friends in new guise": exploiting privileged structures for scaffold re-evolution/refining Comb. Chem. High Throughput Screen. 17 2014 536 553
64. P. Zhan, and et al. Benzimidazole heterocycle as a privileged scaffold in antiviral agents Mini-Rev. Org. Chem. 9 2012 397 410
65. K. Nuyts, and et al. Facile azide formation via diazotransfer reaction in a copper tube flow reactor Tetrahedron Lett. 56 2015 1687 1690
66. K.D. Yamajala, and et al. Pd-catalyzed regioselective arylation on the C-5 position of N-aryl 1,2,3-triazoles J. Org. Chem. 80 2015 3003 3011
67. J. Totobenazara, and A.J. Burke New click-chemistry methods for 1,2,3-triazoles synthesis: recent advances and applications Tetrahedron Lett. 56 2015 2853 2859
68. H.W. Bai, and et al. Aerobic oxidative cycloaddition of α-chlorotosylhydrazones with arylamines: general chemoselective construction of 1,4-disubstituted and 1,5-disubstituted 1,2,3-triazoles under metal-free and azide-free conditions Org. Lett. 17 2015 2898 2901
69. P. Zhan, and et al. Strategies for the discovery of target-specific or isoform-selective modulators J. Med. Chem. 2015 10.1021/acs.jmedchem.5b00229
70. A. Gagnon, and et al. Investigation on the role of the tetrazole in the binding of thiotetrazolylacetanilides with HIV-1 wild type and K103N/Y181C double mutant reverse transcriptases Bioorg. Med. Chem. Lett. 19 2009 1199 1205
71. G.M. Maggiora On outliers and activity cliffs - why QSAR often disappoints J. Chem. Inf. Model. 46 2006 1535
72. P. Zhan, and et al. Functional roles of azoles motif in anti-HIV agents Curr. Med. Chem. 18 2011 29 46
73. P. Zhan, and et al. Sulfanyltriazole/tetrazoles: A promising class of HIV-1 NNRTIs Mini Rev. Med. Chem. 9 2009 1014 1023
74. C.J. Monceaux, and et al. Triazole-linked reduced amide isosteres: an approach for the fragment-based drug discovery of anti-Alzheimer's BACE1 inhibitors Bioorg. Med. Chem. Lett. 21 2011 3992 3996
75. Y. Zou, and et al. Discovery of pyrazole as C-terminus of selective BACE1 inhibitors Eur. J. Med. Chem. 68 2013 270 283
76. Y. Wu, and et al. Flipping in the pore: discovery of dual inhibitors that bind in different orientations to the wild-type versus the amantadine-resistant S31N mutant of the influenza A virus M2 proton channel J. Am. Chem. Soc. 136 2014 17987 17995
77. S. Kumar, and et al. Indoleamine 2,3-dioxygenase is the anticancer target for a novel series of potent naphthoquinone-based inhibitors J. Med. Chem. 51 2008 1706 1718
78. U.F. Röhrig, and et al. Rational design of 4-aryl-1,2,3-triazoles for indoleamine 2,3-dioxygenase 1 inhibition J. Med. Chem. 55 2012 5270 5290
79. A.C. Knall, and et al. Kinetic studies of inverse electron demand Diels-Alder reactions (iEDDA) of norbornenes and 3,6-dipyridin-2-yl-1,2,4,5-tetrazine Tetrahedron Lett. 55 2014 4763 4766
80. H. Xu, and L.H. Jones Click chemistry patents and their impact on drug discovery and chemical biology Pharm. Pat. Anal. 4 2015 109 119
81. C.E. Hoyle, and C.N. Bowman Thiol-ene click chemistry Angew. Chem. Int. Ed. Engl. 49 2010 1540 1573
82. V.J. Gillet New directions in library design and analysis Curr. Opin. Chem. Biol. 12 2008 372 378
83. Y. Zhou, and et al. Application of efficient synthetic techniques in drug research Yao Xue Xue Bao 48 2013 1014 1030
84. S. Ding, and et al. Using a build-and-click approach for producing structural and functional diversity in DNA-targeted hybrid anticancer agents J. Med. Chem. 55 2012 10198 10203
85. A. Brik, and et al. A quick diversity-oriented amide-forming reaction to optimize P-subsite residues of HIV protease inhibitors Chem. Biol. 9 2002 891 896
86. B. Yang, and et al. Discovery of potent KIFC1 inhibitors using a method of integrated high-throughput synthesis and screening J. Med. Chem. 57 2014 9958 9970
87. F.S. Liang, and et al. Epoxide opening in water and screening in situ for rapid discovery of enzyme inhibitors in microtiter plates Bioorg. Med. Chem. 14 2006 1058 1062
88. J. Dong, and et al. Sulfur(VI) fluoride exchange (SuFEx): another good reaction for click chemistry Angew. Chem. Int. Ed. Engl. 53 2014 9430 9448
89. A. Brik, and et al. Microtiter plate based chemistry and in situ screening: A useful approach for rapid inhibitor discovery Org. Biomol. Chem. 4 2006 1446 1457
90. E. Ruijter, and et al. Multicomponent reaction design in the quest for molecular complexity and diversity Angew. Chem. Int. Ed. Engl. 50 2011 6234 6246
91. R. Srinivasan, and et al. Solid-phase assembly and in situ screening of protein tyrosine phosphatase inhibitors Org. Lett. 10 2008 2295 2298